Back to Search

A Phase II Randomized Study of Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection


  • Protocol Number: 202111158
  • Principal Investigator: Ansstas, George
  • Cancer Types: Melanoma & Skin

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

Protocol Interventions